ENTRY       D10593                      Drug
NAME        Roxadustat (JAN/USAN/INN);
            Evrenzo (TN)
FORMULA     C19H16N2O5
EXACT_MASS  352.1059
MOL_WEIGHT  352.3407
CLASS       Metabolizing enzyme substrate
             DG02918  CYP2C8 substrate
             DG02924  UGT substrate
              DG03188  UGT1A9 substrate
            Transporter substrate
             DG01913  ABCG2 substrate
             DG02859  SLC22A6 substrate
             DG02860  SLC22A8 substrate
             DG02856  SLCO1B1 substrate
            Transporter inhibitor
             DG02862  ABCG2 inhibitor
             DG02865  SLCO1B1 inhibitor
REMARK      Therapeutic category: 3999
            ATC code: B03XA05
            Product: D10593<JP>
EFFICACY    Anti-anemic, Prolyl hydroxylase inhibitor
COMMENT     Treatment of anemia
TARGET      EGLN (HPH) [HSA:54583 112398 112399] [KO:K09592]
  PATHWAY   hsa04066(112398+112399+54583)  HIF-1 signaling pathway
METABOLISM  Enzyme: CYP2C8 [HSA:1558], UGT1A9 [HSA:54600]
            Transporter: ABCG2 [HSA:9429], SLCO1B1 [HSA:10599], SLC22A6 [HSA:9356], SLC22A8 [HSA:9376]
INTERACTION Transporter inhibition: ABCG2 [HSA:9429], SLCO1B1 [HSA:10599]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B03 ANTIANEMIC PREPARATIONS
               B03X OTHER ANTIANEMIC PREPARATIONS
                B03XA Other antianemic preparations
                 B03XA05 Roxadustat
                  D10593  Roxadustat (JAN/USAN/INN) &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D10593  Roxadustat (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG02918  CYP2C8 substrate
               D10593  Roxadustat
              DG02924  UGT substrate
               DG03188  UGT1A9 substrate
                D10593  Roxadustat
             Transporter substrate
              DG01913  ABCG2 substrate
               D10593  Roxadustat
              DG02859  SLC22A6 substrate
               D10593  Roxadustat
              DG02860  SLC22A8 substrate
               D10593  Roxadustat
              DG02856  SLCO1B1 substrate
               D10593  Roxadustat
             Transporter inhibitor
              DG02862  ABCG2 inhibitor
               D10593  Roxadustat
              DG02865  SLCO1B1 inhibitor
               D10593  Roxadustat
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               HIF hydroxylase
                EGLN (HPH)
                 D10593  Roxadustat (JAN/USAN/INN) &lt;JP&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10593
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10593
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10593
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10593
             Drug transporters
              D10593
DBLINKS     CAS: 808118-40-3
            PubChem: 254741555
            ChEBI: 132774
            PDB-CCD: 8HO
ATOM        26
            1   C8x C     5.3900  -15.4000
            2   C8x C     5.3900  -16.8000
            3   C8x C     6.5800  -17.5000
            4   C8x C     7.8400  -16.8000
            5   C8y C     7.8400  -15.4000
            6   C8x C     6.5800  -14.7000
            7   O2a O     9.0300  -14.7000
            8   C8y C    10.2200  -15.4000
            9   C8x C    10.2200  -16.8000
            10  C8x C    11.4800  -17.5000
            11  C8y C    12.6700  -16.8000
            12  C8y C    12.6700  -15.4000
            13  C8x C    11.4800  -14.7000
            14  C8y C    13.8600  -17.5000
            15  C8y C    15.1200  -16.8000
            16  N5x N    15.1200  -15.4000
            17  C8y C    13.8600  -14.7000
            18  C1a C    13.8600  -13.3000
            19  O1a O    13.8600  -18.9000
            20  C5a C    16.3100  -17.5000
            21  N1b N    17.5000  -16.8000
            22  O5a O    16.3100  -18.9000
            23  C1b C    18.6900  -17.5000
            24  C6a C    19.8800  -16.8000
            25  O6a O    21.0700  -17.5000
            26  O6a O    19.8800  -15.4000
BOND        28
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     5   7 1
            8     7   8 1
            9     8   9 2
            10    9  10 1
            11   10  11 2
            12   11  12 1
            13   12  13 2
            14    8  13 1
            15   11  14 1
            16   14  15 2
            17   15  16 1
            18   16  17 2
            19   12  17 1
            20   17  18 1
            21   14  19 1
            22   15  20 1
            23   20  21 1
            24   20  22 2
            25   21  23 1
            26   23  24 1
            27   24  25 1
            28   24  26 2
///
